Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Cancer ORigin Epigenetics-Harbinger Health - Collection of Blood and Tissue Samples From Cancer and Non-Cancer Subjects for Validation of a Novel Blood-Based Multi-Cancer Screening Test

NCT05435066 is registered in ClinicalTrials.gov with Harbinger Health as lead sponsor.

NCT NCT05435066
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05435066 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Cancer ORigin Epigenetics-Harbinger Health - Collection of Blood and Tissue Samples From Cancer and Non-Cancer Subjects for Validation of a Novel Blood-Based Multi-Cancer Screening Test
Lead sponsor
Harbinger Health
Phase
Observational
Overall status
Completed
Start date
June 21, 2022
Completion date
June 11, 2025
Enrollment
8,038 (actual)
Sites
128

Conditions

As the registry lists them; a condition with its own page is linked.

cancer